167 related articles for article (PubMed ID: 18564355)
1. Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia.
Coll-Mulet L; Santidrián AF; Cosialls AM; Iglesias-Serret D; de Frias M; Grau J; Menoyo A; González-Barca E; Pons G; Domingo A; Gil J
Br J Haematol; 2008 Sep; 142(5):793-801. PubMed ID: 18564355
[TBL] [Abstract][Full Text] [Related]
2. Identification of chromosomal abnormalities relevant to prognosis in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification.
Stevens-Kroef M; Simons A; Gorissen H; Feuth T; Weghuis DO; Buijs A; Raymakers R; Geurts van Kessel A
Cancer Genet Cytogenet; 2009 Dec; 195(2):97-104. PubMed ID: 19963108
[TBL] [Abstract][Full Text] [Related]
3. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study.
Fabris S; Scarciolla O; Morabito F; Cifarelli RA; Dininno C; Cutrona G; Matis S; Recchia AG; Gentile M; Ciceri G; Ferrarini M; Ciancio A; Mannarella C; Neri A; Fragasso A
Genes Chromosomes Cancer; 2011 Sep; 50(9):726-34. PubMed ID: 21638517
[TBL] [Abstract][Full Text] [Related]
4. Detection of risk-identifying chromosomal abnormalities and genomic profiling by multiplex ligation-dependent probe amplification in chronic lymphocytic leukemia.
Buijs A; Krijtenburg PJ; Meijer E
Haematologica; 2006 Oct; 91(10):1434-5. PubMed ID: 17018399
[TBL] [Abstract][Full Text] [Related]
5. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in chronic lymphocytic leukaemia.
Coll-Mulet L; Gil J
Clin Transl Oncol; 2009 Apr; 11(4):194-8. PubMed ID: 19380295
[TBL] [Abstract][Full Text] [Related]
7. Contribution of MLPA to routine diagnostic testing of recurrent genomic aberrations in chronic lymphocytic leukemia.
Véronèse L; Tournilhac O; Combes P; Prie N; Pierre-Eymard E; Guièze R; Veyrat-Masson R; Bay JO; Vago P; Tchirkov A
Cancer Genet; 2013; 206(1-2):19-25. PubMed ID: 23313109
[TBL] [Abstract][Full Text] [Related]
8. [Genomic abnormalities detected by panel fluorescence in situ hybridization in chronic lymphocytic leukaemia].
Li Q; Xue YQ; Jiang HY; Pan JL; Wu YF; Yang YB
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):324-6. PubMed ID: 15952127
[TBL] [Abstract][Full Text] [Related]
9. [The interphase fluorescence in situ hybridization (I-FISH) technique in patients with chronic lymphatic leukemia (CLL)].
Michalová K; Zemanová Z; Cmunt E; Karban J; Brezinová J; Sindelárová L; Kurková S; Kubcová S; Schwarz J
Cas Lek Cesk; 2000 Jun; 139(11):334-8. PubMed ID: 10953412
[TBL] [Abstract][Full Text] [Related]
10. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
[TBL] [Abstract][Full Text] [Related]
11. Improved testing for CMT1A and HNPP using multiplex ligation-dependent probe amplification (MLPA) with rapid DNA preparations: comparison with the interphase FISH method.
Slater H; Bruno D; Ren H; La P; Burgess T; Hills L; Nouri S; Schouten J; Choo KH
Hum Mutat; 2004 Aug; 24(2):164-71. PubMed ID: 15241798
[TBL] [Abstract][Full Text] [Related]
12. Multiplex ligation-dependent probe amplification versus multiprobe fluorescence in situ hybridization to detect genomic aberrations in chronic lymphocytic leukemia: a tertiary center experience.
Al Zaabi EA; Fernandez LA; Sadek IA; Riddell DC; Greer WL
J Mol Diagn; 2010 Mar; 12(2):197-203. PubMed ID: 20093390
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
[TBL] [Abstract][Full Text] [Related]
15. Translocations as a mechanism for homozygous deletion of 13q14 and loss of the ATM gene in a patient with B-cell chronic lymphocytic leukemia.
Herholz H; Kern W; Schnittger S; Haferlach T; Dicker F; Haferlach C
Cancer Genet Cytogenet; 2007 Apr; 174(1):57-60. PubMed ID: 17350468
[TBL] [Abstract][Full Text] [Related]
16. Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia.
Carter A; Lin K; Sherrington PD; Atherton M; Pearson K; Douglas A; Burford A; Brito-Babapulle V; Matutes E; Catovsky D; Pettitt AR
Leukemia; 2006 Apr; 20(4):737-40. PubMed ID: 16437137
[No Abstract] [Full Text] [Related]
17. Genomic abnormalities in chronic lymphocytic leukemia influence gene expression by a gene dosage effect.
Dickinson JD; Joshi A; Iqbal J; Sanger W; Bierman PJ; Joshi SS
Int J Mol Med; 2006 May; 17(5):769-78. PubMed ID: 16596259
[TBL] [Abstract][Full Text] [Related]
18. Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia.
Patel A; Kang SH; Lennon PA; Li YF; Rao PN; Abruzzo L; Shaw C; Chinault AC; Cheung SW
Am J Hematol; 2008 Jul; 83(7):540-6. PubMed ID: 18161787
[TBL] [Abstract][Full Text] [Related]
19. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia.
Ripollés L; Ortega M; Ortuño F; González A; Losada J; Ojanguren J; Soler JA; Bergua J; Coll MD; Caballín MR
Cancer Genet Cytogenet; 2006 Nov; 171(1):57-64. PubMed ID: 17074592
[TBL] [Abstract][Full Text] [Related]
20. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
Ouillette P; Erba H; Kujawski L; Kaminski M; Shedden K; Malek SN
Cancer Res; 2008 Feb; 68(4):1012-21. PubMed ID: 18281475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
